How do children with drug-resistant epilepsy sleep? A clinical and video-PSG study

• Published in: Epilepsy & behavior 2021-01, Vol.114 (Pt A), p.107320-107320, Article 107320
• Main Authors: Arhan, Ebru, Uçar, Habibe Koç, Aydın, Kürsad, Hirfanoğlu, Tugba, Serdaroglu, Ayse
• Format: Article
• Language: English
• Subjects: Child; Drug-resistant epilepsy; Epilepsy; Humans; Newly diagnosed epilepsy; Pediatric polysomnography; Pharmaceutical Preparations; Polysomnography; Sleep; Sleep Wake Disorders - etiology
• ISSN: 1525-5050; 1525-5069
• DOI: 10.1016/j.yebeh.2020.107320

The aim of this study was to assess sleep architecture and sleep problems among three homogenous groups of children including children with drug-resistant focal epilepsy, children with newly diagnosed, drug-naïve focal epilepsy, and healthy children using overnight video-polysomnography (V-PSG) and a sleep questionnaire. We compared sleep architecture among 44 children with drug-resistant focal epilepsy, 41 children with newly diagnosed, drug naïve focal epilepsy, and 36 healthy children. All children underwent an overnight V-PSG recording, and their parents completed the Children's Sleep Habits Questionnaire (CSHQ). Sleep recordings were scored according to the American Academy of Sleep Medicine criteria. Compared with children with newly diagnosed epilepsy and healthy controls, children with drug-resistant epilepsy receiving antiepileptic treatment showed disturbed sleep architecture, a significant reduction in time in bed, total sleep time, sleep efficiency, NREM3%, REM%, and a significant increase in awakenings, wake after sleep onset, and periodic leg movement. Children with drug-naïve, newly diagnosed focal epilepsy showed a statistically significant increase in sleep onset latency, rapid eye movement (REM) latency, N1%, awakenings, and a significant decrease in time in bed when compared with the controls. Children with drug-resistant epilepsy had the highest CSHQ total scores, while children with drug-naïve, newly diagnosed focal epilepsy had higher scores than healthy children. This is one of the few polysomnographic studies adding to the limited research on the sleep macrostructure of children with drug-resistant epilepsy compared with children with drug-naïve, newly diagnosed focal epilepsy and healthy children by obtaining objective measurements of sleep concurrently with a validated questionnaire. Children with drug-resistant epilepsy had a greater incidence of sleep disturbance on the basis of qualitative aspects and architecture of sleep than children with newly diagnosed epilepsy, suggesting the need for referral of children with drug-resistant epilepsy for overnight sleep evaluation in order to improve the clinical management and optimize therapeutic strategies. •Clinically significant sleep problems are more remarkable in children with drug resistant epilepsy•Children with drug resistant epilepsy receiving antiepileptic treatment have disturbed sleep architecture, decreased sleep efficiency, more awakenings, presence of excessive leg movem